Trunk Impairment Scale - Adaptation and Validation in French (NCT07419087) | Clinical Trial Compass
RecruitingNot Applicable
Trunk Impairment Scale - Adaptation and Validation in French
France67 participantsStarted 2026-03-19
Plain-language summary
The objective of this project is to verify the validity and determine the clinimetric properties after translation and adaptation into French of the Trunk Impairment Scale (TIS), a scale for measuring trunk control and seated balance.
Who can participate
Age range
18 Years – 85 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria (Phase 1):
* Patients over 18 years of age
* Patients who have had a stroke
* Full understanding of the French language
* No cognitive disorders
* No prior exposure to the TIS scale
* Covered by a social security system
* Having been informed, having agreed to participate in the study, and having signed the free and informed consent form.
Inclusion criteria (Phase 2):
* Patients aged over 18 and under 85 years
* Having had a stroke, with no time-since-onset limitation
* Able to sit for 10 seconds without hand support
* Able to provide informed consent
* With an NIHSS score between 2 and 26
* Covered by a social security system
* Having been informed, having agreed to participate in the study, and having signed the free and informed consent form
Exclusion Criteria (Phase 1):
* Insufficient command of the French language
* Inability to understand instructions
* Persons deprived of liberty (by judicial or administrative decision)
* Adults under legal protection or unable to express their consent
* Pregnant or breastfeeding women
Exclusion Criteria (Phase 2):
* Contraindication to the sitting position or to hip adduction (hip prosthesis)
* History of orthopedic or neurological disorders affecting sitting balance
* Insufficient command of the French language
* Inability to understand instructions
* Person deprived of liberty (by judicial or administrative decision)
* Adult under legal protection or unable to express consent
* Pregnant or breastfeeding wom…
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial is focused on adapting and validating a scale called the Trunk Impairment Scale into French — it's not testing a treatment, so what would my participation actually involve, and how might it benefit my care or the care of future stroke patients?
2Since this study is measuring 'content validity,' meaning it's checking whether a assessment tool accurately captures trunk impairment after a stroke, would taking part in it affect or delay any of my actual rehabilitation treatment in any way?
3The trial isn't recruiting yet — given where I am right now in my recovery after my stroke or TIA, is the timing likely to work out, and is this something worth revisiting when it opens?
4Because this is a validation study rather than a treatment trial, are there any risks to participation at all, or is it mainly about completing assessments and giving feedback on the scale?
5Would the information gathered from my participation in this scale validation study be used in my own clinical care, or is it purely for research purposes to help develop better assessment tools for French-speaking stroke patients?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Content validity
Timeframe: Through Phase 1 completion (up to 6 months)
Trial details
NCT IDNCT07419087
SponsorCentre Mutualiste de Rééducation et de Réadaptation Fonctionnelles de Kerpape